Metformin monotherapy in youth with recent onset type 2 diabetes: Experience from the prerandomization run-in phase of the TODAY study.

Authors

Lori Laffel, Joslin Diabetes Center, Lanham, MD
Nancy Chang, Children's Hospital Los Angeles, Los Angeles, CA
Margaret Grey, Yale University
Dan Hales, University of Texas at San Antonio
Laurie Higgins, Joslin Diabetes Center, Lanham, MD
Kathryn Hirst, George Washington University
Roberto Izquierdo, State University of New York Upstate Medical University
Mary Larkin, Massachusetts General Hospital
Christina Macha, Yale University
Trang Pham, George Washington University
Aimee Wauters, University of Texas at San Antonio
Ruth S. Weinstock, State University of New York Upstate Medical UniversityFollow

Document Type

Journal Article

Publication Date

8-2012

Journal

Pediatric Diabetes

Volume

Volume 13, Issue 5

Inclusive Pages

385-391

Keywords

Diabetes Mellitus; Type 2--drug therapy; Hypoglycemic Agents--therapeutic use; Metformin--therapeutic use

APA Citation

Laffel, L., Chang, N., Grey, M., Hale, D., Higgins, L., Hirst, K., . . . , R. S. (2012). Metformin monotherapy in youth with recent onset type 2 diabetes: Experience from the prerandomization run-in phase of the TODAY study. Pediatric Diabetes, 13(5), 385-391.

Peer Reviewed

1